In this month’s issue of DDN…
‘How is it that a drug with the potential to halve a patient’s risk of dying ends up killing so many people? The answer is horribly simple: while most patients are safer on methadone, the wider population are at continued risk from diverted supplies of the drug.’
In the September DDN, Dave Marteau discusses whether or not it’s time for us to reappraise our relationship with the life-saving drug methadone.
Click on the links below to read more, and don’t forget to join the discussion by commenting, tweeting and liking our Facebook page.